Related Experiment Video

Updated: Aug 23, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Fetal neural tube defects: maternal serum and amniotic fluid activin A levels

P Florio, G Lambert-Messerlian, F M Severi

    Prenatal Diagnosis
    |August 10, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
    05:44

    Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1

    Published on: May 17, 2024

    Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment
    08:53

    Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment

    Published on: March 24, 2026

    Related Experiment Videos

    Last Updated: Aug 23, 2026

    Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
    03:19

    Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

    Published on: June 28, 2024

    Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
    05:44

    Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1

    Published on: May 17, 2024

    Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment
    08:53

    Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment

    Published on: March 24, 2026

    Related Concept Videos

    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    Neurulation01:30

    Neurulation

    Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...

    Articles linked to this work by shared authors, journal, and citation graph.

    Placenta accreta spectrum: clinical and radiological follow-up after conservative management and maternal complications.

    European journal of obstetrics, gynecology, and reproductive biology·2026

    Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023.

    Facts, views & vision in ObGyn·2024

    Low prolactin level identifies hypoactive sexual desire disorder women with a reduced inhibition profile.

    Journal of endocrinological investigation·2023

    Cardiometabolic risk is unraveled by color Doppler ultrasound of the clitoral and uterine arteries in women consulting for sexual symptoms.

    Scientific reports·2021

    ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy.

    European journal of endocrinology·2021

    What is the role of glycemic control in the development of preeclampsia among women with type 1 diabetes?

    Pregnancy hypertension·2021

    Non-Invasive Prenatal Diagnosis of Haemoglobinopathies: From Concept to Clinical Reality.

    Prenatal diagnosis·2026

    Transplacental Flecainide and/or Digoxin for Fetal Tachyarrhythmias: Therapeutic Efficacy and Clinical Experience.

    Prenatal diagnosis·2026

    Microbial Culture Profiles Following Fetal Surgery Versus Spontaneous Preterm Prelabor Rupture of Membranes in Multifetal Gestations.

    Prenatal diagnosis·2026

    Standardized Technique for Full Laser Ablation of Feeding Artery in Fetuses With Bronchopulmonary Sequestration and Large Pleural Effusion: Lessons Learned Over 14 Years of Experience.

    Prenatal diagnosis·2026

    Genetic Analysis in Monochorionic Diamniotic Twins Discordant for One Fetus With Structural Anomalies.

    Prenatal diagnosis·2026

    First-Trimester Cell-Free DNA Screening for Common Trisomies Using Rolling-Circle Amplification: A Prospective Study.

    Prenatal diagnosis·2026

    Pregnancy-Related Right Atrial Appendage Tachycardia Requiring ECMO and Hybrid Ablation.

    JACC. Case reports·2026

    Association Between Sperm DNA Fragmentation Index and Outcomes of Fresh Embryo Transfer in IVF/ICSI Cycles: A Retrospective Cohort Study.

    Andrology·2026

    Embryological and Clinical Outcomes in Couples With Autosomal Dominant Polycystic Kidney Disease Undergoing PGT-M: A Retrospective Cohort Study.

    Andrology·2026

    [Morphology of the kidneys in the antenatal period].

    Arkhiv patologii·2026

    Beyond the Biomarkers: Gestation-Dependent Roles of sFLT-1 and PlGF in Human and Non-Human Mammalian Placental Development and Function.

    Cells·2026

    Routine Vitamin and Iron Biomarkers Do Not Explain Variation in Anti-Müllerian Hormone: Implications for Ovarian Reserve Testing in Clinical Practice.

    Journal of clinical medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us